RNAZ

Conviction 0HealthcareScan · Mon, Aug 10, 2026

RNAZ$4.00+1.01%

ResistanceSupportVol 14

Vol MA14 16.3K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Transcode Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.transcodetherapeutics.com ↗

Price4.00

Change+1.01%

Gap+3.28%

Rel volume0.07×

Avg volume15.03K

Avg $ vol87.42K

SMA 205.73

SMA 505.95

SMA 2008.06

Price vs 50-32.82%

Price vs 200-50.35%

MA stackbearish

50/200 cross—

Supertrendup · 0.9414

RSI (14)43

MACD hist-0.20

MACD cross—

Stoch %K / %D50 / 47

ADX (14)15

+DI / −DI31 / 38

RSI divergence—

MACD divergence—

ATR %+28.34%

ADR %10.51%

52w high15.23

52w low0.0000

From 52w high-73.74%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width155.35%

%B0.31

Donchian pos42.58%

Donchian high9.40

Donchian low0.0000

AVWAP (52w high)11.05

vs AVWAP high-63.82%

AVWAP (52w low)8.95

vs AVWAP low-55.29%

OBV trendDown

Chaikin MF (20)-0.47

Today vs 20d0.07×

Avg vol (14d)16.3K

Avg vol (20d)15.03K

Avg $ vol (20d)87.42K

Market cap—

RS 3m (vs SPY)-53.93%

RS 6m (vs SPY)-74.39%

RS line new highNo

Trend template0/8

Technical rank3.9

1 week-5.21%

1 month-54.70%

3 months-45.36%

6 months-55.11%

1 year-62.44%

YTD-45.95%

P/E-0.11

P/B3.04

P/S—

P/FCF-0.19

EPS-52.59

Div yield—

ROE—

ROA-22.05%

Debt/Eq—

Current3.11

EV/EBITDA0.32

Gross margin—

Net margin—

Rev growth—

EPS growth-106.87%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-9.03M

Revenue—

Net income-17.79M

Gross profit—

Free cash flow-19.52M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out950.3K

Employees12

ListedFri, Jul 9, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank3.9 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance10.04

Support2.04

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RNAZ

All disclosures →

No recent disclosed trades by Congress in RNAZ. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RNAZ · 2 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
DEFJ, LLC 10% owner · Common Stock · 2026-08-03	Convert	11.81M	—	2026-08-03	2026-08-05
DEFJ, LLC 10% owner · Common Stock · 2026-08-03	Convert	2.02M	—	2026-08-03	2026-08-05
DEFJ, LLC 10% owner · Series A Non-Voting Convertible Preferred Stock · 2026-08-03	Convert	1.18K	—	2026-08-03	2026-08-05
DEFJ, LLC 10% owner · Series B Non-Voting Convertible Preferred Stock · 2026-08-03	Convert	202.058	—	2026-08-03	2026-08-05

SEC filings

EDGAR filings in RNAZ · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.